| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/01/2001 | US6225530 Flowering locus T (FT) and genetically modified plants having modulated flower development |
| 05/01/2001 | US6225527 Nucleotide sequences associated with response to parasite infection; for the prevention of parasite infection; for the development of disease resistant plants |
| 05/01/2001 | US6225526 Particularly from spinacia oleracea; transgenic plant cell |
| 05/01/2001 | US6225525 ATP-binding cassette transporter (ABC1) modified transgenic mice |
| 05/01/2001 | US6225459 Nucleotide sequences for the expression of heterologous genes; for the treatment of genetic disorders |
| 05/01/2001 | US6225457 Polynucleotide sequences associated with bacterial proteins; for detection of bactericides |
| 05/01/2001 | US6225455 Constructs for producing phosphorylated fusion proteins |
| 05/01/2001 | US6225454 Nucleotide sequences coding enzymatic protein; for use in gene therapy |
| 05/01/2001 | US6225449 Hormone analogs with multiple CTP extensions |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225286 Cell surface protein expressed on human cortical thymocyte and their use |
| 05/01/2001 | US6225285 Semaphorin K1 |
| 05/01/2001 | US6225282 Administration of trkb or trkc agonist neurotrophins; prevention or therapy of ototoxin-induced neuronal damage, loss, or degeneration of spiral ganglion neurons due to certain antibiotics, including aminoglycosides |
| 05/01/2001 | US6225122 Generating immortalized neuronal cells; transfecting cells, propagating on preferential nutrients and detecting transfected cells of interest |
| 05/01/2001 | US6225119 Generating hematopoietic cells in vitro; for use in the treatment of blood disorders |
| 05/01/2001 | US6225118 Multicellular in vitro assay of angiogenesis |
| 05/01/2001 | US6225117 Antibodies against human IL-12 |
| 05/01/2001 | US6225114 Modified gene encoding glyphosate-tolerant 5-enolpruvyl-3-phosphoshikimate synthase |
| 05/01/2001 | US6225112 Human p27Kip1 gene promoter |
| 05/01/2001 | US6225098 UDP-N-acetylenolpyruvyglucosamine reductase |
| 05/01/2001 | US6225091 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus |
| 05/01/2001 | US6225085 Nucleotide and amino acid sequence of leucine-rich surface glycoprotein; diagnosis; prophylaxis; therapy; drug screening; fusion proteins; antigenic peptides; antibodies; recombinant production |
| 05/01/2001 | US6225083 Nucleotide and amino acid sequences of membrane protein involved in cell division; drug screening; bactericides; bacteriostats; antibiotics; for meningitis, sinusitis, conjunctivitis, otitis media, and endocarditis |
| 05/01/2001 | US6225048 Culturing monocytes in fluid communication with viable, allogenically stimulated peripheral blood mononuclear cells to cause differentiation into macrophages, then permitting replication of latent or exogenous virus |
| 05/01/2001 | US6225044 Method for gene transfer into cells activated from a quiescent state |
| 05/01/2001 | US6225042 Culturing genetically engineered, antigen presenting insect cell line so that major histocompatibility class i molecules bound to selected peptide are produced on surface of cell, then contacting with cd8 t cells |
| 05/01/2001 | US6224912 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 05/01/2001 | US6224881 DNA molecule fragments encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 05/01/2001 | US6224879 Genetic engineering |
| 05/01/2001 | US6224868 Reagent and processes for targeting mutant epidermal growth factor receptors |
| 05/01/2001 | US6224860 Method for repopulating human bone marrow comprising culturing CD34+ cells in a serum free medium |
| 05/01/2001 | US6224859 Composition containing immature mammalian dendritic cells for enhancing tolerogenicity to foreign graft |
| 05/01/2001 | US6224858 Hepatocytes transduced with a retroviral vector comprising splice sites and methods of expression |
| 05/01/2001 | CA2324651A1 Split spool type flexible coupling |
| 05/01/2001 | CA2140624C P53 vaccine |
| 05/01/2001 | CA1341223C Dna clone of human tissue factor inhibitor |
| 04/26/2001 | WO2001029564A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029256A2 Cephalic pain susceptibility marker |
| 04/26/2001 | WO2001029255A2 Diagnostic test for cephalic pain |
| 04/26/2001 | WO2001029240A2 Regeneration |
| 04/26/2001 | WO2001029234A2 Self-cleaving rna sequences and their use for the control of protein synthesis |
| 04/26/2001 | WO2001029233A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/26/2001 | WO2001029227A1 The beta-barrel of the lipid body lipoxygenase |
| 04/26/2001 | WO2001029220A2 Mage-a12 antigenic peptides and uses thereof |
| 04/26/2001 | WO2001029213A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | WO2001029209A1 Preparation of cellular components that are substantially free of chromosomal dna |
| 04/26/2001 | WO2001029208A1 Conditional gene trapping construct for the disruption of genes |
| 04/26/2001 | WO2001029207A1 Antiuracil monoclonal antibody |
| 04/26/2001 | WO2001029206A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/26/2001 | WO2001029201A1 Expression of recombinant mature lysostaphin |
| 04/26/2001 | WO2001029199A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 04/26/2001 | WO2001029197A2 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 04/26/2001 | WO2001029195A1 Polypeptides having glucanotransferase activity and nucleic acids encoding same |
| 04/26/2001 | WO2001029193A2 Cell constructs that are suitable for immunotherapy, the production and the use thereof |
| 04/26/2001 | WO2001029192A2 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses |
| 04/26/2001 | WO2001029191A1 Method of in vitro culture of lymphocytes and gene therapy compositions |
| 04/26/2001 | WO2001029190A1 New lymphocytes, a process for preparing the same and their use in therapeutics |
| 04/26/2001 | WO2001029189A2 Synthetic substrate for tissue formation |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029129A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/26/2001 | WO2001029083A1 POLYNUCLEOTIDES ENCODING HUMAN AND MURINE ADHESION PROTEINS (BIgR) |
| 04/26/2001 | WO2001029071A2 Genes associated with obesity and methods for using the same |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029069A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
| 04/26/2001 | WO2001029063A2 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029058A1 Rna interference pathway genes as tools for targeted genetic interference |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001028574A2 Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain |
| 04/26/2001 | WO2001028545A2 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 04/26/2001 | WO2001028342A1 Oligodendrocyte cell cultures and methods for their preparation and use |
| 04/26/2001 | WO2001028324A1 Methods for identifying a preferred liver transplant donor |
| 04/26/2001 | WO2001028321A1 Diabetes onset model mammal |
| 04/26/2001 | WO2001005970A3 Gtp-binding protein associated factors |
| 04/26/2001 | WO2001000788A3 Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000073421A3 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells |
| 04/26/2001 | WO2000071723A3 Methods for regulating protein conformation using molecular chaperones |
| 04/26/2001 | WO2000070021A3 Differentiated human embryoid cells and a method for producing them |
| 04/26/2001 | WO2000066753A3 Modified vitamin k-dependent polypeptides |
| 04/26/2001 | WO2000066743A3 Viral expression vectors |
| 04/26/2001 | WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/26/2001 | WO2000046585A3 Method for enriching or depleting tumour cells obtained from a body fluid and kit suitable for this purpose |
| 04/26/2001 | WO2000011219A9 Subtle mitochondrial mutations as tumor markers |
| 04/26/2001 | WO2000003244A3 Immortalized human keratinocyte cell line |
| 04/26/2001 | US20010000488 Transforming the host cell with nucleic acid encoding the polypeptide factor, transforming host cell with nucleic acid coding desired protein and culturing the transformed host cell in a medium lacking the polypeptide factor |
| 04/26/2001 | DE19950921A1 New isolated nucleic acid encoding sequence that targets proteins to lipid bodies, useful for producing transgenic plants for lipid and fatty acid production |
| 04/26/2001 | DE19949589A1 Differentiating immature myeloid precursor cells, useful for producing active granulocytes for treatment of infections, comprises in vitro culture |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | CA2388497A1 Method of producing differentiated progenitor cells by culturing morula or inner cell mass cells |
| 04/26/2001 | CA2388450A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | CA2388346A1 A method for stimulating root or shoot initiation in plant tissue culture by introducing a recombinant receptor kinase gene |
| 04/26/2001 | CA2388305A1 The beta-barrel of the lipid body lipoxygenase |
| 04/26/2001 | CA2388032A1 Polynucleotides encoding human and murine adhesion proteins (bigr) |
| 04/26/2001 | CA2388003A1 Expression of recombinant mature lysostaphin |
| 04/26/2001 | CA2387928A1 Genes associated with obesity and methods for using the same |
| 04/26/2001 | CA2387748A1 Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain |
| 04/26/2001 | CA2387737A1 Conditional gene trapping construct for the disruption of genes |
| 04/26/2001 | CA2387580A1 Synthetic substrate for tissue formation |
| 04/26/2001 | CA2387559A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |